查詢結果分析
相關文獻
- Safety and Efficacy of Bimatoprost 0.03% as Replacement Therapy in Taiwanese Patients with Glaucoma or Ocular Hypertension Inadequately Controlled by Latanoprost Monotherapy
- Timoptol-XE[feb9] 及Timoptol[feb9] 用於青光眼或高眼壓症病人之比較性研究
- 後房注射Alpha-chymotrypsin誘發之高眼壓兔眼模式之房水動力學變化
- Latanoprost (Xalatan[feb9])--新作用機制的青光眼與高眼壓用藥
- Unoprostone isopropyl(Rescula[feb9])--治療青光眼與高眼壓的新藥
- Travoprost Ophthalmic Solution (Travatan[feb9])--治療青光眼與高眼壓再添新藥
- 高眼壓和早期隅角開放性青光眼之鑑別診斷
- 青光眼臨床試驗之臨床應用:高眼壓症治療臨床試驗及正常眼壓性青光眼臨床試驗
- Effects of Latanoprost 50 ug/ml on Chinese Patients with Primary Open-Angle Glaucoma and Ocular Hypertension
- Ocular Complications after a Sub-Tenon Injection of Triamcinolone Acetonide for Uveitis葡萄膜炎病患接受結膜間質下注射Triamcinolone後相關的眼部併發症
頁籤選單縮合
題 名 | Safety and Efficacy of Bimatoprost 0.03% as Replacement Therapy in Taiwanese Patients with Glaucoma or Ocular Hypertension Inadequately Controlled by Latanoprost Monotherapy=露明目點眼液劑0.03%(Bimatoprost 0.03%)對使用舒而坦點眼液劑0.005%(Latanoprost 0.005%)單一療法後未被完全控制的青光眼或高眼壓患者之替代療法的療效及安全性研究 |
---|---|
作 者 | 呂大文; 梁章敏; 陳怡豪; 陳美如; | 書刊名 | Journal of Medical Sciences |
卷 期 | 26:5 民95.10 |
頁 次 | 頁165-171 |
分類號 | 418.2323 |
關鍵詞 | 青光眼; 高眼壓; 點眼液劑; Bimatoprost; Latanoprost; Glaucoma; Ocular hypertension; Taiwanese; |
語 文 | 英文(English) |